iShares U.S. Pharmaceuticals ETF (IHE)

Delayed Data
As of Feb 16
 +0.95 / +0.62%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines- but excludes producers of vitamins. The fund is non-diversified.

Solid Q4 Earnings Drive Pharma ETF Outlook
Feb 09 / - Paid Partner Content


1 month-2.83% 3 years-0.39%
3 months+2.73% 5 years+12.46%
1 year+2.95% Since inception+11.63%
Data through 02/17/2018

Quote Details

Previous close$154.27
Open day’s range154.37 – 155.55
Net asset value (NAV)154.96 (02/16/2018)
Daily volume7,860
Average volume (3 months)28,321
Data as of 3:59pm ET, 02/16/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+12.46%+17.28%
Expense Gross exp ratio0.44%1.31%
Risk 5 year sharpe ratio0.871.11
Net assets$480.3M$3.2B
Average market cap$17.0B$9.5B
Average P/E28.122.6
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson9.87%
PFE Pfizer8.46%
MRK Merck7.77%
BMY Bristol-Myers Squibb6.31%
LLY Eli Lilly and Co5.48%
AGN Allergan5.32%
ZTS Zoetis Inc4.49%
MYL Mylan NV3.92%
PRGO Perrigo Company PLC2.97%
JAZZ Jazz Pharmaceuticals PLC2.64%